somatropin

FDA Drug Profile — GENOTROPIN, ZOMACTON, Serostim, Norditropin

somatropin is listed in the FDA National Drug Code directory with 51 NDC codes, marketed under brand names including GENOTROPIN, ZOMACTON, Serostim. Available dosage forms: kit, liquid, injection, solution, solution, injection, powder, lyophilized, for solution.

Drug details

Generic Name
somatropin
Brand Names
GENOTROPIN, ZOMACTON, Serostim, Norditropin
Application Number
BLA020280
Sponsor
Pfizer Laboratories Div Pfizer Inc
NDC Codes
51
Dosage Forms
KIT, LIQUID, INJECTION, SOLUTION, SOLUTION, INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION
Routes
SUBCUTANEOUS
Active Ingredients
SOMATROPIN

Indications and Usage

1 INDICATIONS AND USAGE HUMATROPE is a recombinant human growth hormone indicated for: Pediatric Patients: growth failure due to inadequate secretion of endogenous growth hormone (GH); short stature associated with Turner syndrome; Idiopathic Short Stature (ISS), height standard deviation score (SDS) <-2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range; short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency; short stature born small for gestational age (SGA) with no catch-up growth by 2 years to 4 years of age. ( 1.1 ) Adult Patients: replacement of endogenous GH in adults with GH deficiency. ( 1.2 ) 1.1 Pediatric Patients HUMATROPE is indicated for the treatment of pediatric patients with: growth failure due to inadequate secretion of endogenous growth hormone (GH), short stature associated with Turner syndrome, Idiopathic Short Stature (ISS), height standard deviation score (SDS) <-2.25, and associated with growth rates unlikely to permit attainment of adult height in the normal range, short stature or growth failure in short stature homeobox-containing gene (SHOX) deficiency, short stature born small for gestational age (SGA) with no catch-up growth by 2 years to 4 years of age. 1.2 Adult Patients HUMATROPE is indicated for the replacement of endogenous GH in adults with GH deficiency.

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.